News
More than 2 out of 5 American adults are obese, according to the Centers for Disease Control. With this figure in mind, it's ...
Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participants experienced an average weight loss of 7.2 kg with the 36 mg ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results